Showing results (41-50 of 3,858) with videos related to
Sort By:
Pageof 386
Blood|January 7, 1998
Incidence of TEL/AML1 fusion gene analyzed consecutively in children with acute lymphoblastic leukemia in relapseJ Harbott, S Viehmann, A Borkhardt, et al.Klinische Padiatrie|July 1, 1982
[Medulloblastoma study of the German Society for Pediatric Oncology, a first report]M Neidhardt, H J Habermalz, G Henze, et al.Klinische Padiatrie|November 27, 2004
[Concepts of the Society of Paediatric Oncology and Haematology (GPOH) and the German Competence Network in Paediatric Oncology and Haematology for the quality controlled development in paediatric oncology]U Creutzig, H Jürgens, R Herold, et al.Pediatric Hematology and Oncology|May 18, 1999
Neurofibromatosis 1 associated with embryonal rhabdomyosarcoma of the urinary bladderS Reich, U S Overberg-Schmidt, A Leenen, et al.Archives of Disease in Childhood|April 1, 1996
Cerebrospinal fluid soluble L-selectin (sCD62L) in meningoencephalitisC Bührer, R Herold, D Stibenz, et al.Hepatology (Baltimore, Md.)|August 1, 1989
HBcAg expressed on the surface of circulating Dane particles in patients with hepatitis B virus infection without evidence of anti-HBc formationB Möller, U Hopf, R Stemerowicz, et al.Klinische Padiatrie|July 1, 1995
[Long-term infusion of L-asparaginase--an alternative to intramuscular injection?]T Rodriguez, E Baumgarten, R Fengler, et al.Journal of Chromatography. B, Biomedical Applications|November 4, 1994
High-performance liquid chromatographic determination of methotrexate, 7-hydroxymethotrexate, 5-methyltetrahydrofolic acid and folinic acid in serum and cerebrospinal fluidS Belz, C Frickel, C Wolfrom, et al.European Journal of Clinical Pharmacology|January 1, 1990
Pharmacokinetic study of methotrexate, folinic acid and their serum metabolites in children treated with high-dose methotrexate and leucovorin rescueC Wolfrom, R Hepp, R Hartmann, et al.Klinische Padiatrie|July 1, 1990
[Effect of 7S immunoglobulin substitution on the incidence and course of infection in cytostatic drug treated patients]P Hadjilaskari, G Roehrig, R Hartmann, et al.Pageof 386